Alzheimer's disease (AD) is a neurodegenerative disorder and the most common cause of dementia in the elderly. The extracellular accumulation of amyloid-β (Aβ) in senile plaques is a principal event in the pathogenesis and there is growing evidence that the dysregulation of lipid pathways is implicated in the disease, however the link between these two is still under study. In this work, we investigated human brain samples, from 11 AD patients and a control cohort of age-matched subjects without AD, using label-free chemically-specific Raman micro-spectroscopy. The collected image data were quantitatively analysed using an efficient quantitative unsupervised/partially supervised non-negative matrix factorization method, to retrieve the concentration maps and spectra of the samples' chemical constituents. Significant changes in lipid composition as well as increased concentrations of oxidative stress bio-markers were observed in AD tissues compared to the control. In particular, the analysis revealed accumulations of two different lipid components throughout the entire Aβ plaque (highest at the fibrillar core and lowest at the rim). One component is attributed to cholesteryl esters with saturated long-chain fatty acids (FAs), found to co-localise with aggregated Aβ peptides in multi-clusters of about 3 µm average size, which are in turn bundled to each other forming one macro-aggregate templating the Aβ plaque. The other component is attributed to a mixture of fibrin protein and arachidic acid, which are a hallmark of inflammation, and was found to be abundant in fibrillar and core-only plaques. This fibrin/arachidic acid component showed multiple domains of different sizes, ranging from 1 to 5 µm, linked to each other and forming a large structure of shape similar to the plaque. Lipid aggregates and Aβ plaque cores for the AD group were also found to be co-localised with significant accumulations of β-carotene and magnetite (Fe3O4), indicating a high level of oxidative damage implicated in AD human brains. In addition, a non-Aβ protein component was observed to co-deposit with the fibrillar core of hippocampal Aβ plaques, and was attributed to a collagen-like amyloidogenic component (CLAC). Overall, our results reveal abnormal deposits of saturated cholesteryl esters, Aβ fibrils, arachidic acid, fibrin, CLAC, β-carotene and magnetite, co-localising in Aβ plaques of AD human brains. This finding opens perspectives for new anti-inflammatory and antioxidant drug strategies, designed to restore brain homeostasis as potential therapeutics of AD. We also demonstrate by the means of spatial concentration histograms that these identified species separate AD from non-demented control brains, beneficial for AD diagnosis.
I. INTRODUCTION
Alzheimer's disease (AD) is an age-related neurodegenerative disorder, characterized by the extracellular accumulation of Aβ peptide in senile plaques and the intracellular deposits of the microtubule-associated protein tau in the form of neurofibrillary tangles. According to the 2017 Alzheimer's Association report, AD affects one in nine Americans over the age of 65 and becomes increasingly prevalent with age [1] . Alongside obesity and diabetes, AD is a modern disease with consistently increasing number of patients. Despite being considered as a 21st century epidemic, there is still no cure for AD and the etiology of the disease remains obscure. A number of hypotheses such as amyloid cascade, lipid dysregulation, oxidative stress, and inflammation have been proposed in AD brain [15] . On the other hand, there is a line of evidence that lipids themselves have detergent properties, promoting the disintegration of amyloid fibrils into toxic oligomers [16, 17] . These free oligomers can bind to synaptic contacts [18] , where they disrupt membrane homeostasis [19] . Altogether, these findings suggest that the amyloid-lipid complex in Aβ plaques produces toxic species, which are involved in AD's pathology.
Despite the importance of this research, the direct molecular analysis of Aβ plaques and their lipid inclusions in human AD brains, with quantitative information on their spatial distribution and chemical composition, is still very limited. This is partly due to the lack of reliable methods to study lipids with high spatial resolution and chemical specificity in their native microenvironments. Of the imaging tools available, fluorescent microscopy (FM) revealed abnormal deposits of cholesterol in cores of mature Aβ plaques [20] . However, this technique is based on tagging the biomolecules of interest, not allowing to study unknown chemical species. Furthermore, labelling can affect the distribution/composition of the fragile lipids/amyloid co-arrangements. Among spectroscopy techniques, mass spectrometry (MS) provides chemical information on a wide range of molecular contents with high specificity, but requires sample ionization as well as chemical extraction of lipids from tissue samples. For example, liquid chromatography-MS (LC-MS) showed an elevated level of diacylglycerol (∼80% ↑), glucosylceramide (∼43% ↑) and galactosylceramide (∼32% ↑), as well as decreased phosphatidylethanolamine (∼25% ↓) in the prefrontal cortex human brain with AD compared to controls. Furthermore, the AD entorhinal cortex subjects were found to be enriched in lysobisphosphatidic acid (∼80% ↑), sphingomyelin (∼20% ↑), ganglioside GM3 (ceramide-Ntetrose-N-acetylneuraminic acid) (∼64% ↑), and cholesterol esters (CE) (∼70% ↑) in the form of CE-16:1, CE-16:0, and CE-18:1, which are typically associated with lipid droplets [21] . It is possible to combine MS with imaging and achieve spatial resolution from tens of micron (with MALDI) to sub-micron (with second ionization mass spectrometry-SIMS). These MS-based imaging modalities have been applied to image lipid, proteins and metals in brains [22, 23] , however they require sample processing procedures which are damaging and destructive and can not be applied to living specimens.
Vibrational micro-spectroscopies techniques such as infrared absorption [24, 25] and Raman scattering microscopy detect the intrinsic vibrations of chemical bonds in molecules, and thereby provide a non-invasive, labelfree chemically specific imaging method. Infrared microscopy has limited spatial resolution due to the long wavelength of the infrared light. Conversely, Raman micro-spectroscopy can offer sub-micron spatial resolution by using light in the visible range. Notably, in its non-linear version, coherent Raman scattering (CRS) microscopy provides additional improvements in 3D spatial resolution and acquisition speed compared to spontaneous Raman, and has been recently applied to study brain tissues [26] [27] [28] . However CRS suffers from limited signal-to-noise ratio in the vibrational fingerprint range (700-1800 cm −1 ), and in turn reported studies of CRS microscopy of brain tissues examined only the CH-stretch vibrational range (2700-3100 cm −1 ), which is notoriously more congested than the fingerprint region and thus less chemically specific. Surprisingly little work has been reported to date on the chemical profile of AD brains by confocal Raman micro-spectroscopy [29, 30] , and a comprehensive quantitative analysis of the spatially-resolved chemical composition of the lipid-amyloid complex, covering the whole spectral range from fingerprint to CHstretch, in unstained AD human brain tissues is still missing.
In this work, we report an extensive study of the spatial distribution and chemical composition of Aβ plaques, measured by label-free spontaneous Raman micro-spectroscopy in fixed human brain slices from AD patients and age-matched controls and quantified by hyperspectral image factorization method.
II. EXPERIMENTAL SECTION
A. Tissue preparation Human brain tissue was obtained from the Thomas Willis Oxford Brain Collection (TWOBC), which is part of the Medical Research Council (MRC) Brain Bank Network, with the ethical approval of the Research Tissue Bank provided by the Oxford Brain Bank (OBB) Access Committee. Brain tissue samples were recruited from 11 individuals, who at the time of death had AD, and from 4 age-matched humans, which were not diagnosed with AD based on histological examination (see Table 1 ). The AD brain cohort met the standard criteria for AD's neuropathologic diagnosis. A total of 5 hippocampal and 6 cerebral cortex diseased samples were investigated, representing the hippocampus of the first five AD subjects and the frontal lobe of the other six ones. As control, 2 hippocampal and 2 cerebral cortex samples from the corresponding brain regions of non-demented subjects were included in this study. Brain samples were fixed with formalin, paraffin embedded, sectioned into 5 µm thick slices and then mounted on standard glass slides. For Raman micro-spectroscopy measurements, formalin-fixedparaffin-embedded brain sections were deparaffinized using a standard dewaxing protocol: removing the paraffin in xylene (two cycles for 20 minutes each), and rehydrating in a sequence of 100%, 90% and 70% ethanol for 5 minutes each. The slices were then covered with phosphate buffered saline (PBS) and a standard glass coverslip was attached on top. Finally, the mounted samples were sealed with nail varnish applied around the edges of the coverslip. After Raman measurements, the samples were reopened and stained with Thioflavin-S for amyloid fibrils to confirm plaque locations. In the following, we refer to AD and control (C) samples, numbered by individual, as Ah1,..., Ah5 and Ch1, Ch2, respectively, studied in the hippocampus; and as Ac1,..., Ac6, and Cc1, Cc2, studied in the cerebral cortex. A total of 61 Aβ plaques were examined: 30 in the five hippocampal brain samples and 31 in the six cerebral cortex samples from the 11 AD subjects. Specifically, there were: 10, 9, 5, 1, and 5 plaques in the Ah1, Ah2, Ah3, Ah4, and Ah5 hippocampal samples, respectively; and 3, 13, 7, 2, 3, and 3 plaques in the Ac1, Ac2, Ac3, Ac4, Ac5, and Ac6 cortical samples.
B. Optical micro-spectroscopy
Raman imaging was carried out using a home-built multimodal laser-scanning microscope based on an inverted Nikon Ti-U stand, coupled to a Horiba JobinYvon iHR 550 imaging spectrometer (300 grooves/mm grating) and an Andor CCD Newton DU-971N-BV detector (1600x400 pixels, 16 µm pixel size). A laser source (Laser Quantum GEM 532 nm) was used for excitation. The 532 nm laser excitation was filtered by a Semrock LL01-532 clean-up filter, and coupled into the microscope by a dichroic mirror (Semrock LPD01-532RS). Raman scattering was collected in epi-direction, filtered with a long pass filter (Semrock BLP01-532R), and dispersed by the imaging spectrometer. The spectral resolution of the system was 5 cm −1 with 30 µm width of the spectrometer entrance slit, and the measured Raman spectral range covered 330 cm −1 to 4050 cm −1 . Raman imaging for all brain samples was achieved by raster-scanning the sample, using a motorized stage (Prior ProScan III XYZ Controller), through the focal point of the laser beam over a region of interest of about 50 × 50 µm 2 with a step size of 1 µm resulting in a 50×50×1600 points hyperspectral Raman image with a 1 second exposure time per spectrum. All images were taken with 100 mW laser power at the sample, using a 20× 0.75 NA dry objective (Nikon MRD00205) and 1× tube lens. Confocal Raman detection was provided by a horizontal slit (Thorlabs VA100), and the vertical input slit of the spectrometer, both located in an intermediate image plane. The estimated spatial resolution was 0.45 µm in-plane and 0.6 µm axially.
Prior to Raman measurements, an overview image for each sample across 10.4 × 6 mm 2 , made of 24 × 18 tiles with 0.43 × 0.33 mm 2 tile size, was acquired using differential interference contrast (DIC). In the DIC, a deSenarmont compensator provided a phase offset of 20 degrees and a 0.72 NA dry condenser (Nikon MEL56100) with a DIC module (Nikon MEH52400) was used for illumination, combined with a matched DIC slider (Nikon MBH76220) in the objective, giving a shear of about 0.24 µm. A Hamamatsu ORCA 285 camera (1344 × 1024 pixels of 6.45 µm size) at 100 ms frame exposure time was used for detection at lowest gain (4.45 photoelectrons/count). 
C. Data analysis and processing
Raman hyperspectral data were analysed using quantitative unsupervised/partially supervised unmixing method [32] , consisting of the following basic steps (see also the theory, algorithms and data analysis steps in [32] ).
Firstly, the data were noise-filtered using singular-value decomposition (SVD) with automatic divisive correlation, enabling to remove components which are identified as noise using the auto-correlation coefficients for spatial and spectral singular vectors at one pixel shift. Components with a mean auto-correlation coefficient less than 50% were attributed to noise and discarded. This cut-off value was suited to differentiate the meaningful components from noise-dominated ones, as verified by visual inspection and discussed in [32] . Secondly, broad features in the spectra, which represent fluorescent background, were subtracted using the bottom Gaussian fitting with a standard deviation (STD) of 900 cm −1 . Finally, the efficient quantitative unsupervised/partially supervised non-negative matrix factorization (Q-US/PS-NMF) method via a fast combinatorial alternating non-negativity-constrained least squares (ANLS) algorithm was applied to the noisefiltered background-subtracted data. This algorithm [32] factorizes the spectrally and spatially resolved data into a sum of direct products of non-negative spatial concentration maps and corresponding non-negative spectra, representing biochemical components of sample composition, showing an exponential convergence towards a global minimum. In the factorizations shown here, the remaining factorization error was about 2%. In order to compare the concentrations of different chemical species between samples, the component spectra were normalized to have equal integrals, having a value chosen to result in a sum of the spatial concentrations with a mean of one.
In order to separate the contribution of wax residues to the spectral basis, the spectrum of the paraffin-wax compound, measured on one of the paraffin-embedded sample, was used as a fixed spectral component in the Q-US/PS-NMF. The Raman spectrum of wax is also shown in Figs. S11 and S33 of the Supporting Information, together with the results of factorization analysis of hippocampal and cortical brain tissues.
III. RESULTS AND DISCUSSION
Label-free confocal Raman micro-spectroscopy together with hyperspectral image factorization method (see Sec. II B and Sec. II C) was used to investigate the biochemical composition of Aβ plaques and their environment in AD human brain tissues from the hippocampus and frontal lobe. The quantitative data analysis was performed simultaneously on all data of a given type of brain region (i.e. hippocampus or cortex), enabling a direct comparison of concentration and spatial distribution of chemical components in diseased and control samples.
To identify Aβ plaques, the samples were stained with Thioflavin-S (the "gold standard" for identifying amyloid fibrils [33] ). This was done after Raman imaging, to avoid labelling artefacts and fluorescence background. To identify potential areas containing plaques on labelfree AD samples, we used large scale DIC images. DIC contrast allowed us to identify Aβ plaques regions, which were used for the area selection for Raman measurements of label-free AD samples. To confirm they are plaquepositive, we performed FM of the measured regions on the same samples stained with Thioflavin-S dye.
The factorization analysis revealed that all hyperspectral images were optimally represented using 20 separate components. Detailed discussion on the components' number selection can be found in [32] . In brief, when using 19 components, the algorithm resulted in a higher concentration error, whereas for 21 components one factorization component with a meaningful spectrum which could be attributed to proteins split into two less meaningful ones. Five of these components were found to be spatially co-localized with the Aβ plaques, and exhibited spectra resembling those of known chemical species, as detailed in the following section. We call these components C 1 ..C 5 in the following, sorted in the order of decreasing mean concentration. Notably, four of them were similar in the hippocampal and cortical brain samples, with the remaining one was seen only in the hippocampus. The other 15 components were not significantly colocalized with Aβ plaques. Their description and attribution is given in the Supporting Information.
A. Raman spectra of chemical components colocalized with hippocampal Aβ plaques
The spectra of the 5 chemical components C 1 ...C 5 colocalized with Aβ plaques in hippocampal samples in the fingerprint (736-1780 cm −1 ) and CH-stretch (2793-3122 cm −1 ) regions are given in Fig. 1 . They were obtained analysing data from 30 regions containing Aβ plaques from AD subjects and 10 regions from the control group (see Sec. II A). The ranges below 736 cm −1 and above 3200 cm −1 are dominated by Raman scattering from the glass slide/coverslip and water, respectively, and were therefore excluded from the analysis.
Raman spectra of analytical standards, which resemble the component spectra, are shown for comparison. They were identified using Bio-Rad's KnowItAll Vibrational Spectroscopy software with the Raman Spectral Libraries. The Raman spectra of the identified standards shown in this work were then taken from published papers and are cited accordingly in the following.
The spectrum of C 1 exhibits a series of characteristic bands, at 1657 cm −1 (Amide I, α-helix), 1554 cm −1 (Amide II), 1338 cm −1 (CH 2 wagging vibrations from glycine (Gly) backbone and proline (Pro) side chain), 1267 cm −1 (Amide III), 1206 cm −1 (hydroxyproline (Hyp) and tyrosine (Tyr)), 1031 cm −1 (Pro), 1002 cm −1 (phenylalanine), 934 cm −1 (C-C backbone), 852 cm −1 (Pro, Hyp, Tyr), which are consistent with the Raman bands of collagen [34] . Furthermore, the spectrum shows a notable band at 1705 cm −1 , which is characteristic for the C=O stretching vibration of amino acids. This band might be originated from Gly-Pro-X and Gly-X-Hyp sequence (where X is any amino acid), which are the most common motifs of collagen.
It has been previously reported that senile plaques extracted from AD human brains contain a collagen-like amyloidogenic component (CLAC), which is associated with collagen XXV [35] . In vitro studies show that addition of a collagen-like triple-helical peptide to the amyloidogenic peptide significantly delays its nucleation and fibril growth [36] . Relating to the C=O vibration observed for C 1 , these studies hypothesised that the C=O moieties in the repeating Gly-Pro-Hyp sequences within the triple-helix collagen can bind to backbone amides or to glutamine/asparagine side chains of the amyloid-like peptide, hampering its nucleation. Other relationships between collagen and amyloid suggest the neuroprotective potential of collagen VI against Aβ neurotoxicity by blocking the association of Aβ oligomers with neurons, protecting against fragmentation of Aβ plaques, thereby preventing neurotoxicity [37] .
The spectra of C 2 and C 3 show bands characteristic of a mixture of lipids, with C 2 additionally showing bands that can be related to proteins. In particular, the fingerprint region of C 3 exhibits bands at 1060, 1129, and 1293 cm −1 , assigned to C-C skeletal stretching vibrations, and the CH 2 twisting mode of fatty acids, respectively [38, 39] . The presence of a strong 2880 cm −1 band in the CH-stretch region (the asymmetric CH 2 stretch enhanced by the Fermi resonance interaction with the overtones of CH 2 and CH 3 deformations) combined with a relatively weak band around 2933 cm −1 (a combination of CH 3 and CH 2 asymmetric vibrations enhanced by the broadening and shift of the CH deformations in the liquid phase) [40] , is typical of a saturated lipid in the solid phase. We find that the spectrum of C 3 can be well described (using reference spectra and NLS fitting) as a mixture (red dotted line) of 79% fibrin (magenta line) [41] and 21% arachidic acid (green line) [39] in both the fingerprint and CH-stretch regions. We therefore attribute C 3 to a mixture of fibrin protein and saturated FA, resembling arachidic acid. This observation is in line with previous studies on fibrin deposition in plaque areas of AD mouse brains [42] . Furthermore, the same studies have suggested that fibrin might play a central role in the initiation and progression of the inflammatory process in AD, possibly promoting neurodegeneration. Neuronal damage of AD brains correlated with fibrin deposits is supported by our observation, revealing co-deposition of arachidic acid, as a marker of oxidative damage in tissue, with fibrin.
The spectrum of C 2 reveals an acyl chain order, given by the ratio between the intensity at 2880 cm −1 and at 2850 cm −1 , twice as high as C 3 , and a strong band at 1673 cm −1 , which can be attributed to the superposition of the C=O stretching vibration of the protein backbone (Amide I band) from a high content of β-sheet protein structure, with the C=C stretching vibration mode in cholesterol [38] and in the FA chain of E -unsaturated FAs (trans-configuration) [34] . Notably, the formation of trans double bonds (1670 cm −1 ) results from the conversion of cis double bonds (1655 cm −1 -not present in C 2 ) during lipid peroxidation [43] . The spectrum of C 2 in the fingerprint region can be well described (red dotted line) by a mixture of 81% of synthetic Aβ (1-42) fibrils (spectrum available only in the fingerprint region [44] ), which can be associated with the core of Aβ plaques with predominately β-sheet protein structure (magenta line), and 19% cholesteryl palmitate (green line) [39] . The CHstretch region is found to be similar to the reference spectrum of cholesteryl palmitate. We therefore attribute C 2 to a mixture of two chemical constituents: Aβ (1-42) peptide, aggregated in amyloid fibrils with β-sheet confirmation, and cholesteryl derivatives with saturated long-chain FA chains, forming lipid aggregates. The occurrence of this mixed component in the analysis indicates that the constituents are co-localized within the spatial resolution of the data, suggesting that amyloid and cholysteryl-ester lipid bodies form a tightly connected structure in the samples. The combination of Aβ protein and cholesteryl ester was discussed in previous studies on cholesterol-mutant cell lines, where it was found that Aβ generation is up-regulated with a selective increase of cholesteryl ester levels, regulated by acylcoenzyme A:cholesterol acyltransferase (ACAT) [45] . The same studies have shown that pharmacological ACAT inhibitors sufficiently suppress both cholesteryl ester and Aβ biosynthesis, indicating their potential for use in the therapy of Alzheimer's disease. Recently, this strategy has been confirmed on an AD mice model [46] . Furthermore, the solid lipids might be associated with lipid droplets, originated either from microglia or the lipid transporter protein apolipoprotein E (ApoE). The former is suggested by previous observations that lipid microvesicles, secreted by microglia, are shown to adhere to fibrillar plaques, from where they extract toxic Aβ oligomers, implying one of the possible mechanism of lipid deposition [47] . The latter is suggested by a study showing that the ApoE-lipid complex binds to fibrillar Aβ plaques, where it modulates its aggregation and clearance [48] .
The spectrum of C 4 shows three sharp bands characteristic of carotenoids, at 1007 cm −1 , 1154 cm −1 , and 1518 cm −1 , which can be assigned to the methyl rocking vibrational mode, C-C, and C=C in-phase stretch vibrations of the polyene chain, respectively [49] . Furthermore, the relative intensities of the bands are comparable with those for pure β-carotene (red dotted line), confirming its attribution to β-carotene. Notably, this component is particularly enriched in cortical plaques, as will be detailed in Sec. III D. Note that while average carotenoid concentrations in control and AD brain tissue from the frontal lobe and occipital cortex have been reported, which for β-carotene species account for 4.5 ng/g in Alzheimer's brains compared to 5.5 ng/g in normal elderly ones, there is still no information about its spatial distribution and correlation with Aβ plaques. Furthermore, the role of β-carotene and other carotenoids in lipid peroxidation in free radical-affected diseases, such as AD, cardiovascular diseases, atherosclerosis, and cancer is controversial [50, 51] . For example, it was shown in vitro that β-carotene can act as either anti-or prooxidant depending on its concentration and the oxygen partial pressure in tissue [52] .
The spectrum of C 5 is found to be consistent with Fe 3 O 4 [53] (see red dotted line). In fact, the presence of redox metal ions including iron has been observed for AD brains, making them vulnerable to oxidative damage [54] . Furthermore, it has been recently observed by electron holography that iron nanoparticles co-localise with the cores of Aβ plaques [55] . There is growing evidence that a high affinity of Aβ peptides for metal ions results in the formation Aβ-metal complexes, and that metal ions in turn induce the oligomerization of toxic Aβ species [56] .
B. Concentration maps of chemical components in hippocampal Aβ plaques
In this section, we examine and compare the spatiallyresolved maps of the concentrations of the chemical components identified in the previous section, across AD and non-demented populations in the hippocampal brain region. Fig. 2 shows representative examples of Aβ plaques with different morphologies, namely fibrillar ( Fig. 2A, Fig. 2F , 50 × 50 µm 2 from Ch2). Row 1 shows DIC images taken before Raman imaging, and Row 2 shows fluorescent images of the same plaques, taken after staining with Thioflavin-S, with the white squares indicating the regions of Raman imaging. Rows 3 to 7 show the concentrations of C 1 to C 5 , respectively. The concentration maps exhibit an accumulation of the selected components in plaque areas compared to control regions. Generally, C 1 (CLAC), C 2 (fibrillar Aβ (1-42) and saturated cholesteryl esters), and C 3 (fibrin and arachidic acid) show a similar spatial distribution.
In the fibrillar plaque, C 1 , C 2 , and C 3 are clustered in multi-domains of various sizes, which are linked to each other, forming one macro-aggregate, templating the plaque. Notably, the distribution of C 5 (iron oxide) is co-localized with C 1 , C 2 , and C 3 , except from small high density clusters, which seem to exclude the other components. C 4 instead is essentially absent.
The cored neuritic plaque, apart from being more spatially localized, shows a similar contribution of the different components, except for the collagen component, which is not observed in its oligomeric halo, as seen from the void areas in its concentration map (Fig. 2B3) , which are filled by iron (C 5 ) in the centre, and lipids (C 3 ) around.
The core-only plaque shows higher concentrations and a high degree of co-localization of all components. Fur-
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thermore, a significant concentration of C 4 (β-carotene) is found surrounding the core of plaque.
The diffuse neuritic plaque has a similar morphology as the fibrillar plaque, but with lower concentrations of each component, except C 4 . Notably, C 2 and C 5 are found not to be co-localized.
In contrast to plaque areas, the two control regions have smaller concentrations of C 2 , C 3 , C 4 , and C 5 . However, C 1 is found to have relatively high concentrations, which are rather evenly distributed, representing extracellular matrix. Fig. 3 shows the colocalization histograms of the concentrations of C 2 and C 3 (top row) and of C 2 and C 1 (bottom row) for AD and control, combining data from 10, 9, 5, 5 plaques from Ah1, Ah2, Ah3, Ah5, and 6, 4 control regions from Ch1, Ch2 individuals, respectively, each of about 50×50 µm 2 in size. The colocalization histograms for Ah4 sample is shown in the Supporting Information Fig. S22 . The analysis of these histograms reveals a significant difference in concentrations of collagen, Aβ (1-42) fibrils, saturated cholesteryl esters, fibrin and arachidic acid between AD and control groups, indicating their potential to be used for discrimination of patients' classes. In particular, as can be seen from Fig. 3 , we can take a cut-off value of the distributions histograms at concentrations of 15%, 5%, and 15%, 28% for components 2, 3 (top row) and components 2, 1 (bottom row), respectively, which results in only histograms for AD group having concentrations higher than these values, therefore indicating that the hippocampal AD samples are differentiated from the non-AD controls on the basis of these concentration distributions.
C. Raman spectra of the chemical components in cortical Aβ plaques
From our Raman micro-spectroscopy measurements and quantitative factorization analysis on cortical AD samples together with non-demented controls, we find four key chemical components, which are co-localized with cortical Aβ plaques. These are: a mixture of fibrillar Aβ (1-42) and saturated lipids with cholesteryl derivatives (C 2 ), a mixture of cholesterol and cholesteryl esters with saturated FA chains (C 3 ), β-carotene (C 4 ) and Fe 3 O 4 (C 5 ) (see the Supporting Information Figure S46) . Notably, there is no signature of collagen (C 1 in the hippocampus) observed in the cortical plaque regions.
D. Concentration maps of chemical components in cortical Aβ plaques
We compare the concentration maps of the four components identified in Sec. III C over AD and control populations in the cortex brain region. Rows 2-5 in Fig. 4 show the concentration maps, obtained from the analysis on 31 unstained cortical Aβ plaques (6 AD patients) together with 9 control Raman maps (2 age-matched humans without AD). Results are shown on examples of Aβ plaques of three different morphologies: two neuritic (40×40 µm 2 from Ac1 in column A, 64×64 µm 2 from Ac2 in column B), core-only (55 × 55 µm 2 from Ac2 in column C), cored neuritic (64×64 µm 2 from Ac3 in column D), and two control regions (64×64 µm 2 from Cc1 in column E, and 32×32 µm 2 from Cc2 in column F). FM of plaque and two control regions, stained with Thioflavin-S, are shown in row 1, where white squares represent the regions investigated with Raman micro-spectroscopy. The corresponding DIC images of the same plaque and control areas are shown in the Supporting Information
core-only plaque (Ac2) . White areas in panels B2-B5 represent pixels which were excluded from the analysis due to too strong fluorescence.
Compared to the hippocampal data, we find a similar behaviour of C 2 and C 3 . However, the collagen component C 1 is absent, and all plaques show large β-carotene (C 4 ) and iron oxide (C 5 ) concentrations similar to the coreonly plaque in the hippocampal data. Also here, the β-carotene tends to be in the periphery of the plaque.
We find that the concentration maps of the aggregated Aβ peptides and saturated lipids with high cholesteryl ester content (C 2 ) in the plaque areas (Fig. 4(A2-D2) ) correlate well with the corresponding fluorescent images of Thioflavin-S dye (Fig. 4(A1-D1) ). The concentration maps of fibrin/arachidic acid (C 3 ), β-carotene (C 4 ) and iron oxide (C 5 ) across the different types of plaques show their elevated micro-scale accumulations throughout the entire plaque areas, highest at the fibrillar core and lowest at the Aβ rim. In contrast to AD plaque regions, the controls do not to contain significant amounts of β-carotene (Fig. 4(E4,F4) ) or iron molecules (Fig. 4(E5,F5) ). Notably, the fibrin/arachidic acid component is found not only inside the plaque, but also outside of it, whereas β-carotene and iron species are exclusively observed inside the plaque.
The elevated deposits of β-carotene, iron oxide, Aβ fibrils, and saturated lipids, which are found to be colocalised in Aβ plaques, can reflect the presence of neuroinflammation and a high level of neurotoxicity in the AD brain. The oxidation status of lipids is supported by the presence of trans double bonds in the Raman spectrum of C 2 (see Sec. III A), forming during lipid peroxidation. Furthermore, the presence of arachidic acid (eicosanoic acid) in C 3 indicates the conversion of arachidonic acids to eicosanoids occurring in the process of oxidative damage. Notably, Raman bands which are characteristic for secondary oxidation products, such as short-chain hydrocarbons (produced from the reaction of lipid hydroperoxide and redox metal), are obtained when analyzing AD samples only in Aβ plaque regions (data Colocalization histograms of concentration (%) for β-carotene (C4) and iron oxide (C5) components for each diseased (4 AD patients) and control (2 subjects) cortex samples, which refer to AD and non-demented age-matched subjects, labelled as Ac1 (A), Ac2 (B), Ac3 (C), Ac4 (D) and Cc1 (E), Cc2 (F), representing the statistics on 3, 13, 7, 2 plaques, and 4, 3 control regions, respectively, each of about 50×50 µm 2 in size.
not shown). Altogether, our data show that AD brains contain huge amounts of oxidative stress markers, colocalised with amyloid/lipids in Aβ plaques, and thereby indicating the critical role of oxidative damage in AD pathogenesis. In terms of Aβ plaque aggregation, it is possible that the plaque environment, shown to consist of abnormal micro-complexes of fibrin/arachidic acid, saturated cholesteryl esters, β-carotene and iron oxide, controls the degree of plaque aggregation/fragmentation and, therefore, the neurotoxicity status of AD human brains. Colocalization histograms of concentration are shown in Fig. 5 , for the β-carotene (C 4 ) and iron oxide (C 5 ) components of each diseased (4 AD patients) and control (2 age-matched subjects without AD) samples, using data of 3, 13, 7, 2 plaques from Ac1, Ac2, Ac3, Ac4, and 4, 3 control regions from Cc1, Cc2 individuals, each of about 50×50 µm 2 in size. The corresponding concentration histograms for Ac5 and Ac6 samples are shown in the Supporting Information Fig. S45 . The analysis of the distribution histograms again reveals striking changes in the concentrations of these components between AD and control populations, indicating their potential capability to differentiate patients' classes, similar to what discussed for the hippocampus regions (see Sec. III B). In particular, as can be seen from Fig. 5 , taking the cut-off value of the distributions histograms at concentrations of 5% and 3% for components 4 and 5, respectively, results in only histograms for AD cohort having concentrations higher than these values, therefore again indicating that AD population of the cerebral cortex tissue can be separated from non-demented age-matched group on the basis of these concentration distributions.
IV. CONCLUSION
We have performed an extensive Raman microspectroscopy study coupled with quantitative factorization analysis in AD human brain tissues. We have found micro-scale accumulations of chemical components attributed to cholesteryl esters with saturated long-chain FAs, Aβ fibrils, fibrin/arachidic acid, CLAC, β-carotene and magnetite, co-localising in Aβ plaques of AD human brains. Notably, our study reveals that aggregated Aβ peptide co-exists with saturated cholesteryl esters in one complex, representing one chemical component. This result suggests that cholesteryl esters might play an important role in Aβ metabolism. Our observations support previous in vitro studies, demonstrating that the inhibition of ACAT function, which keeps the balance between free cholesterol and cholesteryl ester levels in the brain, down-regulates Aβ biosynthesis, therefore implying the use of ACAT inhibitors as potential therapy in the treatment of AD. Moreover, significant accumulation and co-localisation of β-carotene and magnetite (Fe 3 O 4 ) with lipid aggregates and Aβ plaque cores suggests that a high level of oxidative damage is implicated in AD human brains. Importantly, we have shown, by the means of colocalization histograms, that these chemical substances can differentiate AD brains from non-demented ones, implying their potential to be used in the diagnosis of AD.
Data Availability
The Raman micro-spectroscopy data created during this research will be openly available from Cardiff University data archive at https://doi.org/10.17035/d.2018.0046308965 soon.
